What OCR keeps citing.
Since 2024 the Office for Civil Rights has settled more than a dozen HIPAA enforcement actions under the Risk Analysis Initiative. The cited deficiency is verbatim across the press releases — and it is not about encryption, access controls, or training. It is about the inventory underneath the analysis.
By the CybrIQ team · 8 minute read
The sentence that keeps appearing.
"Failure to conduct an accurate and thorough risk analysis of the potential risks and vulnerabilities to the confidentiality, integrity, and availability of all electronic protected health information held by the covered entity." Read three OCR press releases from 2024 or 2025 and you will see it twice. Read ten and you will recognize it on sight. The single word doing the work in that sentence is accurate.
An inventory missing the biomedical VLAN, the vendor service-engineer laptop, the imaging modality installed last quarter, or the pharmacy automation cabinet with its vendor tunnel back to the manufacturer is, by definition, not accurate. Every one of those omissions has appeared as a contributing factor in published resolution agreements. The risk analysis was completed. The methodology was documented. The inventory it referenced was wrong.
Why inventory is the load-bearing control.
Every other control in HIPAA Security Rule §164.308 depends on it. You cannot perform a risk analysis on devices you cannot enumerate. You cannot implement risk management on risks you have not identified. You cannot evaluate the periodic security activities of §164.308(a)(8) without baseline visibility into what is being secured. The inventory is the foundation of the analysis is the foundation of the program. OCR is working that dependency tree from the bottom up, and the bottom keeps cracking.
What the inventory of record misses.
The pattern is consistent across investigations: the asset list reflects the corporate Active Directory, the network's IP-managed endpoints, and the systems documented in the Clinical Engineering CMMS. That sounds comprehensive. It is not. It misses biomedical devices on isolated VLANs that turn out not to be isolated. It misses imaging modalities the vendor installed without an asset ticket. It misses pharmacy automation cabinets whose vendor tunnel was never documented to IT. It misses the contractor laptop on the corporate VLAN because guest wifi did not reach the conference room. Six categories, every one of them recurring, none of them exotic.
The methodology paragraph that survives interview.
OCR investigators do not just read the risk analysis. They interview the team that produced it. The interview question that breaks programs is "how do you know the inventory you analyzed is accurate?" The answer that survives is a documented methodology with a continuous source of truth, a reconciliation cadence against the CMMS, and timestamped change records that an auditor can pull for any date in the prior fiscal year.
The answer that does not survive is "we update the inventory before the audit."
The cycle that makes inventory rebuilding pointless.
Six weeks of audit prep produces an accurate inventory for the day the auditor reviews it. The next day the inventory drifts again. The cycle repeats annually. The investigator who arrives mid-cycle gets the drifted version, not the rebuilt one. The defense against this is not better rebuilds. The defense is making the inventory continuously accurate so there is no rebuild to do.
The bottom of it.
OCR will keep citing the same finding because the same finding keeps producing the same incidents. The pattern is not about HIPAA-specific risk; it is about whether anyone in the organization can prove, on any given Tuesday, what is on the network and how they know. Programs that can answer that question hold up under inspection. Programs that cannot, do not.
If your inventory is the gap that worries you, the methodology that closes it is what CybrIQ is built around. The technical reference is at cybriq.io/technology. The 30-day pilot terms are at cybriq.io/pilot; the inventory we produce during the pilot is yours regardless of whether you continue with us.